| ［1］ Chatterjee D. The mycobacterial cell wall:structure, biosynthesis and sites of drug action ［J］. Curr Opin Chem Biol, 1997, 1(4):579-588.［2］ Richards OW.The staining of acid-fast tubercle bacteria ［J］. Sci, 1941, 93:190.［3］ George KM, Yuan Y, Sherman DR,Barry CE III. The biosynthesis of cyclopropanated mycolic acid in mycobacterium tuberculosis ［J］. J Biol Chem, 1995,270(45):27292-27298.［4］ Yuan Y, Lee RE, Besra G.S, Belisle JT, Barry CE IIII. Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids inMycobacterium tuberculosis［J］. Proc Natl Acad Sci USA, 1995,92(14):6630 -6634.［5］ Takayama K, Wang C, Besra GS. Pathway to synthesis and processing of mycolic acids inMycobacterium tuberculosis［J］.Clin Microbiol Rev,2005, 18(1):81-101.［6］ Schweizer E,Hofmann J. Microbial type I fatty acid synthases(FAS):major players in a network of cellular FAS systems ［J］. Microbiol Mol Biol Rev, 2004, 68(3):501-517.［7］ Bhatt A, Molle V, Besra GS, Jacobs WR Jr, Kremer L. TheMycobacterium tuberculosisFAS-II condensing enzymes:their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development ［J］. Mol. Microbiol, 2007, 64(6):1442-1454.［8］ Gao LY, Laval F, Lawson EH, Groger RK, Woodruff A, Morisaki JH, Cox JS, Daffe M,Brown EJ. Requirement for kasB inMycobacteriummycolic acid biosynthesis, cell wall impermeability and intracellular survival:implications for therapy ［J］. Mol Microbiol,2003, 49(6):1547-1563.［9］ Mduli KR, Slayden A, Zhu Y, Ramaswamy S, Pan X, Mead D, Crane DD, Musser JM, Barry CE III. Inhibition of aMycobacterium tuberculosisβ-ketoacyl ACP synthase by isoniazid ［J］. Sci, 1998, 280 (5369):1607-1610. ［10］ Dessen A, Quemard A, Blanchard JS, Jacobs WR, Sacchettini JC. Crystal structure and function of the isoniazid target of in Mycobacterium tuberculosis［J］. Sci, 1995, 267(5204):1638-1641.［11］ Glickman MS. The mmaA2 gene ofMycobacterium tuberculosisencodes the distal cyclopropane synthase of the α-mycolic acid［J］. J Biol Chem, 2003, 278(10):7844-7849.［12］ Glickman MS, Cahill SM,Jacobs WR Jr. A novel mycolic acid cyclopropane synthetase is required for coding persisterce, and virulence ofMycobacterium tuberculosis［J］. Mol Cell, 2000, 5(4):717-727.［13］ Portevin D, De Sousa-D'Auria C, Houssin C, Grimaldi C, Chami M, Daffe M, Guilhot C. A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organism ［J］. Proc Natl Acad Sci USA, 2004, 101(1):314-319.［14］ Smith I.Mycobacterium tuberculosispathogenesis and molecular determinants of virulence ［J］. Clin Microbiol Rev, 2003, 16(3):463-496. ［15］ Clifton E, Barry III, Mdluli K. Drug sensitivity and environmental adaptation of mycobacterial cell wall components ［J］. Trends Microbiol, 1996, 4:275-281.［16］ Koch-Wester D, Ebert RH, Barclay WR, Lee VS.Studies on the metabolic significance of acid-fastness of tubercle bacilli ［J］. J Lab Clin Med, 1953, 42:828-829.［17］ Takayama K, Wang L, David HL. Effect of isoniazid on the vivo mycolic acid synthesis, cell growth and viability ofMycobacterium tuberculosis［J］. Antimicrob Agents Chemother, 1972, 2(1):29-35.［18］ Quémard A, Lacave C, Lanéelle G. Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of mycobacterium aurum ［J］. Antimicrob Agents Chemother, 1991, 35(6):1035-1039.［19］ Kruh NA, Rawat R, Ruzsicska BP, Tonge P J. Probing mechanisms of resistance to the tuberculosis drug isoniazid:conformational changes caused by inhibition of InhA, the enoyl reductase fromMycobacterium tuberculosis［J］. Prot Sci, 2007, 16(8):1617-1627. ［20］ Phetsuksiri B, Baulard A, Cooper A, Minnikin DE, Douglas JD, Besra GS, Brennan PJ. Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis ［J］. Antimicrob Agents Chemother, 1999, 43(5):1042-1051.［21］ Lévy-frébault V, Goh KS and David HL. Mycolic acid analysis for clinical identification of mycobacterium avium and related mycobacteria ［J］. J Clin Microbiol, 1986, 24(5):835-839.［22］ Ikawa H, Oka S, Murakami H, Hayashi A, Yano I. Rapid identification of serotypes of mycobacterium avium-M.intracellulare complex by using infected swine sera and reference antigenic glycolipids ［J］.J Clin Microbiol, 1989, 27(11):2552-2558.［23］ Bosne S.,Lévy-frébault V. Mycobactin analysis as and aid for the identification of mycobacterium fortuitum and mycobacterium chelonae subspecies ［J］. J Clin Microbiol, 1992, 30(5):1225-1231.［24］ Portaels F, Dawson DJ, Larsson L, Rigouts L.Biochemical properties and fatty acid composition of mycobacterium haemophilum:study of 16 isolates from Australian patients ［J］. J Clin Microbiol, 1993, 31(1):26-30.［25］Ozbek A, Aktas O. Identification of three strains of mycobacterium species isolated from clinical samples using fatty acid methyl ester profiling ［J］. J Intl Med Res., 2003, 31(2):133-140.［26］ Smid I, Salfinger M. Mycobacterial identification by computer-aided gas liquid chromatography ［J］. Diagn Microbiol Infect Dis, 1994, 19(2):81-88.［27］ Dworzanski JP, Berwald L, Meuzelaar HLC. Pyrolytic methylation-gas chromatography of whole bacterial cells for rapid profiling of cellular fatty acids ［J］. Appl Enviro Microbiol, 1990, 56(6):1717-1724.［28］ Alugupalli S, Sikka MK, Larsson L, White DC. Gas chromatography-mass spectrometry methods for the analysis or mycocerosic acids present in Mycobacterium tuberculosis［J］.J Microbiol Methods, 1998, 31(3):143-150.［29］ Luquin M, Lopez F, Ausina V. Capillary gas chromatographic analysis of mycolic acid cleavage products, cellular fatty acids, and alcohols of mycobacterium xenopi ［J］. J Clin Microbiol, 1989, 27(6):1403-1406.［30］ Lambert MA, Moss CW, Silcox VA, Good RC. Analysis of mycolic acid cleavage products and cellular fatty acids of mycobacterium species by capillary gas chromatography ［J］. J Clin Microbiol, 1986, 23(4):731-736.［31］ Kellogg JA, Bankert DA, Withers GS, Sweimler W, Kiehn TE, Pfyffer GE. Application of the Sherlock mycobacteria identification system using high-performance liquid chromatography in a clinical Laboratory ［J］. J Clin Microbiol, 2001, 39(3):964-970.［32］ Butler WR,Kilburn JO. High-performance liquid chromatography patterns of mycolic acid as criteria for identification of mycobacterium chelonae,mycobacterium fortuitum and mycobacterium smegmatis ［J］. J Clin Microbiol, 1990, 28(9):2094-2098［33］ Hagen SR, Thompson JD. Analysis of mycolic acids by high-performance liquid chromatography and fluorimetric detetion implication for the identification of mycobacterium heidelbergense sp.nov. ［J］.J Chromatogr, 1995, 672(1-2):167-172［34］ Parrish N, Osterhout G., Dionne K, Sweeney A, Kwiatkowski N, Carroll K, Jost KC Jr, Dick J.Rapid, standardized method for determination ofMycobacterium tuberculosisdrug susceptibility by use of mycolic acid analysis ［J］. J Clin Microbiol, 2007, 45(12):3915-3920.［35］ Laval F, Lanéelle M-A, Deón C, Monsarrat B, Daffé M. Accurate molecular mass determination of mycolic acids by MALDI-TOF mass spectrometry ［J］. Anal Chem, 2001, 73(18):4537-4544. ［36］ Ballell L, Field RA, Duncan K, Young RJ. New small-molecule synthetic antimycobacterials ［J］. Antimicro Agents Chemother, 2005, 49(6):2153-2163. |
京公网安备11010202007215号
ip访问总数: ip当日访问总数: 当前在线人数:
本作品遵循Creative Commons Attribution 3.0 License授权许可
